Ankylosing spondylitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
710
|
609
|
0.010 |
None |
< 0.001 |
1 |
|
2016 |
2016 |
Experimental Organism Basal Cell Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
437
|
63
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Prolactinoma
|
disease |
Neoplasms; Nervous System Diseases; Endocrine System Diseases
|
Neoplastic Process
|
187
|
6
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Skin carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
136
|
24
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Severe Combined Immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
284
|
46
|
0.020 |
None |
0.500 |
2 |
|
2002 |
2020 |
Intraepithelial Neoplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
186
|
|
0.020 |
None |
0.500 |
2 |
|
2010 |
2013 |
Precursor B-cell lymphoblastic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
478
|
23
|
0.020 |
None |
0.500 |
2 |
|
2012 |
2017 |
Myelofibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
163
|
7
|
0.060 |
None |
0.667 |
6 |
|
2006 |
2018 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.030 |
None |
0.667 |
3 |
|
1998 |
2017 |
Myeloid Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
385
|
7
|
0.040 |
None |
0.750 |
4 |
|
2006 |
2017 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.040 |
None |
0.750 |
4 |
|
2016 |
2019 |
Lymphoma, T-Cell, Cutaneous
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
367
|
5
|
0.050 |
None |
0.800 |
5 |
|
2002 |
2016 |
Hematopoietic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
322
|
2
|
0.050 |
None |
0.800 |
5 |
|
2002 |
2019 |
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
220
|
37
|
0.060 |
None |
0.833 |
6 |
|
2006 |
2017 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.060 |
None |
0.833 |
6 |
1
|
2011 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.400 |
None |
0.897 |
39 |
|
1998 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
0.897 |
39 |
|
1998 |
2018 |
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
282
|
29
|
0.100 |
None |
0.900 |
10 |
|
2007 |
2019 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
0.971 |
35 |
1
|
1996 |
2019 |
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.100 |
None |
0.976 |
42 |
1
|
1993 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
53 |
|
2002 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
53 |
1
|
2001 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
32 |
|
2002 |
2020 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.100 |
None |
1.000 |
29 |
3
|
1998 |
2020 |